Prostanoid EP1- and TP-receptors involved in the contraction of human pulmonary veins

British Journal of Pharmacology

Volumn 134, Issue 8, 2001, Pages 1671-1678

  Walch, Laurence ^a   De Montpreville, Vincent ^b   Brink, Charles ^a   Norel, Xavier ^a  

^a CNRS   (France)

^b CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

AH6809; BAY u3405; Contraction; GR32191B; Human pulmonary veins; Iloprost; Prostaglandin; Prostanoid receptors; SC19220; Sulprostone; U46619

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 17 PHENYLPROSTAGLANDIN E2; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; FLUPROSTENOL; ILOPROST; PROSTANOID EP1 RECEPTOR; PROSTANOID EP3 RECEPTOR; PROSTANOID FP RECEPTOR; PROSTANOID RECEPTOR; RAMATROBAN; SULPROSTONE; THROMBOXANE A2 RECEPTOR; UNCLASSIFIED DRUG; VAPIPROST; 17 PHENYL PROSTAGLANDIN E2; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN F2 ALPHA; PROSTANOID; THROMBOXANE RECEPTOR;

ADULT; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PULMONARY VEIN; RECEPTOR BLOCKING; RECEPTOR INTRINSIC ACTIVITY; VENOCONSTRICTION; APPARENT DISSOCIATION CONSTANT; CONCENTRATION (PARAMETER); CONCENTRATION RESPONSE; EC50; MAXIMUM DRUG EFFECT;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; BIPHENYL COMPOUNDS; CARBAZOLES; CULTURE TECHNIQUES; DIBENZ(B,F)(1,4)OXAZEPINE-10(11H)-CARBOXYLIC ACID, 8-CHLORO-, 2-ACETYLHYDRAZIDE; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; HEPTANOIC ACIDS; HUMANS; ILOPROST; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDINS F, SYNTHETIC; PULMONARY VEINS; RECEPTORS, PROSTAGLANDIN; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, THROMBOXANE; SULFONAMIDES; VASOCONSTRICTION; XANTHENES; XANTHONES;

EID: 0035671188     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704423     Document Type: Article

References (71)

1. Reduced responses of retinal vessels of the newborn pig to prostaglandins but not to thromboxane
2. Endothelium-dependent relaxation and effects of prostacyclin, endothelin and platelet-activating factor in human hand veins and arteries
3. Characterization of contraction-mediating prostanoid receptors in human hand veins: Effects of the thromboxane receptor antagonists BM13,505 and AH23848
4. Some quantitative uses of drug antagonists
5. Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery
6. 1 and FP receptor agonists
7. Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes
8. Receptor subtypes involved in dual effects induced by prostaglandin E2 in circular smooth muscle from dog colon
9. 2) prostaglandin E2 receptors in isolated ileal smooth muscle cells
10. Characterization of thromboxane A2 receptors in the human fetal placental vessels and umbilical vein
11. Prostanoid-induced contraction of the rabbit isolated uterus is mediated by FP receptors
12. Contractile and relaxant actions of prostaglandins on guinea-pig isolated trachea
13. Characterisation of the prostanoid receptors mediating contraction of guinea-pig isolated trachea
14. 1 receptor bloking drug
15. Evidence for the existence of three subtypes of PGE2 sensitive (EP) receptors in smooth muscle
16. Further evidence for the existence of three subtypes of PGE2- sensitive (EP-) receptors in smooth muscle
17. Gastric antisecretory prostanoids: Actions at different prostanoid receptors
18. Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors
19. International union of pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes
20. Pharmacological characterization in vitro of prostanoid receptors in the myometrium of nonpregnant ewes
21. Effects of prostaglandins and thromboxane analogues on bullock and dog iris sphincter preparations
22. Prostaglandin E receptor subtypes in smooth muscle: Agonist activities of stable protacyclin analogues
23. The action of prostanoid receptor agonists and antagonists on smooth muscle and platelets
24. Maintenance of functional activity of human pulmonary arteries after cryopreservation
25. 3 subtype mediate the inhibitory effect of prostaglandin E2 on noradrenaline release in the mouse brain cortex
26. 1 subtype
27. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: Distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation
28. The effects of some natural prostaglandins on isolated human circular bronchial muscle
29. 1 receptor
30. Pharmacological nature of TP receptor mediated contraction in human intrapulmonary artery
31. 3-receptor in guinea-pig aorta: Partial agonist action of the non-prostanoid ONO-AP324
32. AH6809, a prostaglandin DP-receptor blocking drug on human platelets
33. Studies on the characterisation of prostanoid receptors: A proposed classification
34. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells
35. Prostaglandin effects on the contractility of bovine trabecular meshwork and ciliary muscle
36. Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum
37. Cardiogenic pulmonary oedema: Presentation of pre-eclampsia exacerbated by prostaglandin abortifacients
38. 2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro
39. A comparison of the contractile responses of rodent and human pulmonary vascular segments to eicosanoids
40. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: Evidence for different receptors
41. Characterisation of receptors mediating the contractile effects of prostanoids in guinea-pig and human airways
42. BAY u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro
43. 3-subtype
44. Molecular mechanisms of diverse actions of prostanoid receptors
45. Inhibitory effects of BAY u3405 on prostanoid-induced contractions in human isolated bronchial and pulmonary arterial muscle preparations
46. Effects of the thromboxane receptor antagonist SK&F 88046 in the canine, monkey and human coronary vasculature
47. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder
48. Prostanoid receptor heterogeneity through alternative mRNA splicing
49. Critical pulmonary edema following cesarean section
50. 3-receptor agonists on human isolated pulmonary artery
51. Evidence for the PGE receptor subtype mediating inhibition of acid secretion in the rat
52. Antagonism of prostaglandin E2 by 1-acetyl-2(8-chloro- 10,11-dihydrodibenz (b, f) (1,4) oxazepine- 10-carbonyl) hydrazine (SC-19220)
53. 2 in vitro
54. In vitro characterization of prostanoid receptors on human myometrium at term pregnancy
55. In vitro characterization of prostanoid FP-, DP-, IP- and TP-receptors on the non-pregnant human myometrium
56. 3 and FP prostaglandin receptor binding sites in bovine corpus luteum: Characterization and correlation with functional data
57. Thromboxanes: Synthase and receptors
58. The strong contractile effect of the thromboxane receptor agonist U-46619 in isolated human pulmonary arteries and its competitive antagonism by BM-13.505
59. Pulmonary edema in association with an intravenous infusion of sulprostone
60. Biphasic actions of prostaglandin E(2) on the renal afferent arteriole: Role of EP(3) and EP(4) receptors
61. The role of endogenous thromboxane in contractions to U46619, oxygen, 5-HT and 5-CT in the human isolated umbilical artery
62. Heterogeneity of thromboxane A2 (TP-) receptors: Evidence from antagonist but not agonist potency measurements
63. 2 alpha in human pial arteries
64. Prostanoid receptors involved in the relaxation of human pulmonary vessels
65. 1 subtype of prostaglandin E receptor
66. 2, FP, or TP prostanoid-receptor stimulation may reduce intraocular pressure
67. 2 alpha effects on intraocular pressure negatively correlate with FP-receptor stimulation
68. 2 alpha ester prodrugs and receptor selective prostaglandin analogs
69. Intraocular pressure effects of selective prostanoid receptor agonists involve different receptor subtypes according to radioligand binding studies
70. 2 receptor antagonist
71. 3 receptors in urethane-anaesthetized rats